<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">DIJ</journal-id>
<journal-id journal-id-type="hwp">spdij</journal-id>
<journal-title>Therapeutic Innovation &amp; Regulatory Science</journal-title>
<issn pub-type="ppub">2168-4790</issn>
<issn pub-type="epub">2164-9200</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
  <article-id pub-id-type="doi">10.1177/2168479012467018</article-id>
  <article-id pub-id-type="publisher-id">10.1177_2168479012467018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Drug Safety</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Validation of QT Interval Correction Methods When a Drug Changes Heart Rate</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Dang</surname>
<given-names>Qianyu</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0092861512467018">1</xref>
<xref ref-type="corresp" rid="corresp1-0092861512467018"/>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Joanne</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0092861512467018">1</xref>
</contrib>
<aff id="aff1-0092861512467018">
<label>1</label>Division of Biometrics VI, Office of Biostatistics, Center of Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0092861512467018">Qianyu Dang, Division of Biometrics VI, Office of Biostatistics, Center of Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20903, USA. Email: <email xlink:type="simple">qianyu.dang@fda.hhs.gov</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>47</volume>
<issue>2</issue>
<fpage>256</fpage>
<lpage>260</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>9</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>10</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="other">Drug Information Association</copyright-holder>
</permissions>
<abstract>
<p>The QT interval is correlated with heart rate; therefore, the QT interval is usually corrected by heart rate when drug-induced QT effect is studied. Currently, there are many correction methods that use either fixed or data-driven approaches. The effectiveness of correction methods depends on many factors and varies from study to study. Statistical validation and comparisons need to be performed to determine the most appropriate correction method for each study. We examined different validation methods and explored a new approach to use when the testing drug changes heart rate.</p>
</abstract>
<kwd-group>
<kwd>QT interval correction</kwd>
<kwd>QT-RR correction validation</kwd>
<kwd>drug-induced heart rate change</kwd>
<kwd>mixed effects model</kwd>
<kwd>drug blood concentration</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0092861512467018">
<title>Introduction</title>
<p>Since 2005, FDA regulators have required that nearly all new molecular entities be evaluated in a thorough QT (TQT) study to determine a drug’s impact on the QT interval.<sup>
<xref ref-type="bibr" rid="bibr1-0092861512467018">1</xref>
</sup> The purpose of such requirement is to assess the effects of drugs on cardiac repolarization. To obtain drug-induced QT intervals, we need to correct the QT interval according to heart rate since the QT interval is related to the heart rate and changes accordingly. In recent years, methods without heart rate correction, such as Holter bin analysis<sup>
<xref ref-type="bibr" rid="bibr2-0092861512467018">2</xref>
</sup> and dynamic QT beat-to-beat analysis,<sup>
<xref ref-type="bibr" rid="bibr3-0092861512467018">3</xref>,<xref ref-type="bibr" rid="bibr4-0092861512467018">4</xref>
</sup> have also been proposed. The Holter bin method compares the uncorrected on- and off-drug QT interval at the same heart rates. The beat-to-beat method compares the uncorrected QT interval to what is called a normal condition for the same heart rate in the same subject. The number for the normality is based on all the baseline data for the study. But at present, most studies still rely on the corrected QT intervals to evaluate the QT liability of the new drugs. Many correction methods have been proposed.<sup>
<xref ref-type="bibr" rid="bibr5-0092861512467018">5</xref>
</sup> They can be categorized into the following 3 types: fixed correction, data-driven correction, and 1-step model correction.</p>
<p> It should be noted that the true relationship between QT interval and heart rate is still unknown even though electrocardiography was introduced more than 100 years ago. Because we lack a biological model, all the existing methods are empirical approaches and there is no consensus as to which one is the best model to universally and accurately describe this relationship or simply to indicate that each individual might have a different shape in the QT–heart rate relationship.<sup>
<xref ref-type="bibr" rid="bibr6-0092861512467018">6</xref><xref ref-type="bibr" rid="bibr7-0092861512467018"/>–<xref ref-type="bibr" rid="bibr8-0092861512467018">8</xref>
</sup>
</p>
<p>The fixed-correction approach assumes that there is a fixed association between QT and heart rate and that it is the same for each individual—any other deviations from this association are just random errors. Popular fixed corrections include the following:</p>
<p>
<disp-formula id="disp-formula1-0092861512467018">
<mml:math id="mml-disp1-0092861512467018" overflow="scroll">
<mml:mi>Q</mml:mi>
<mml:mi>T</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>F</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mi>Q</mml:mi>
<mml:mi>T</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:msup>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mn>3</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mrow>
<mml:mtext mathvariant="normal">'</mml:mtext>
</mml:mrow>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mtext mathvariant="normal"> </mml:mtext>
<mml:mi mathvariant="normal">f</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mi mathvariant="normal">u</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:math>
<graphic alt-version="no" alternate-form-of="disp-formula1-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-eq1.tif" xlink:type="simple"/>
</disp-formula>
</p>
<p>
<disp-formula id="disp-formula2-0092861512467018">
<mml:math id="mml-disp2-0092861512467018" overflow="scroll">
<mml:mi>Q</mml:mi>
<mml:mi>T</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>B</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mi>Q</mml:mi>
<mml:mi>T</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:msup>
<mml:mi>R</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">B</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">z</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mrow>
<mml:mtext mathvariant="normal">'</mml:mtext>
</mml:mrow>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mtext mathvariant="normal"> </mml:mtext>
<mml:mi mathvariant="normal">f</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mi mathvariant="normal">u</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:math>
<graphic alt-version="no" alternate-form-of="disp-formula2-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-eq2.tif" xlink:type="simple"/>
</disp-formula>
</p>
<p>
<disp-formula id="disp-formula3-0092861512467018">
<mml:math id="mml-disp3-0092861512467018" overflow="scroll">
<mml:mi>Q</mml:mi>
<mml:mi>T</mml:mi>
<mml:mi>c</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>Q</mml:mi>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mn>0.154</mml:mn>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>R</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mi mathvariant="normal">h</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mtext mathvariant="normal"> </mml:mtext>
<mml:mi mathvariant="normal">f</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mi mathvariant="normal">u</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
</mml:math>
<graphic alt-version="no" alternate-form-of="disp-formula3-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-eq3.tif" xlink:type="simple"/>
</disp-formula>
</p>
<p> where RR (interval between 2 adjacent R waves in an ECG) = 60,000/heart rate (beats per minute). The fixed-correction methods need to assume a uniform relationship between QT and RR for each subject in the study, which might not be realistic, as pointed out by many researchers.<sup>
<xref ref-type="bibr" rid="bibr6-0092861512467018">6</xref>
</sup>
<sup>-</sup>
<sup>
<xref ref-type="bibr" rid="bibr8-0092861512467018">8</xref>
</sup> There is some evidence showing that each individual has a slightly different QT-RR profile.<sup>
<xref ref-type="bibr" rid="bibr9-0092861512467018">9</xref>
</sup> The data-driven correction methods were designed to resolve this issue by introducing random effects for each individual. Drug-free baseline data from all treatment groups are used to derive the parameters in each individual’s QT-RR correction formula. Then such a formula is applied to postdose QT data to derive corrected QT interval (QTc) for the same subject. The resulted QTc is defined as individual corrected QT (QTcI). The advantage of QTcI is that it does not assume a fixed association between QT and RR for each individual so each one can have his or her unique profile. However, it requires comparably more data for each individual and a wider range of heart rate at baseline to obtain an accurate and precise estimate for each individual’s QT-RR profile. In current crossover or parallel study designs, such requirements are usually not met. Many studies submitted to FDA do not have a wide enough RR range to allow for an accurate estimate of the individual correction factors and thus lead to poor performance of QTcI. Furthermore, some scholars question the validity of linear assumptions between QT and RR; other models with more flexibility have been suggested, such as the following<sup>
<xref ref-type="bibr" rid="bibr6-0092861512467018">6</xref>
</sup>
<sup>-</sup>
<sup>
<xref ref-type="bibr" rid="bibr8-0092861512467018">8</xref>
</sup>:
<disp-formula id="disp-formula4-0092861512467018">
<label>1</label>
<mml:math id="mml-disp4-0092861512467018" overflow="scroll">
<mml:mi>Q</mml:mi>
<mml:mi>T</mml:mi>
<mml:mi>c</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>Q</mml:mi>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mo stretchy="false">×</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>R</mml:mi>
<mml:msup>
<mml:mi>R</mml:mi>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:msup>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
<graphic alt-version="no" alternate-form-of="disp-formula4-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-eq4.tif" xlink:type="simple"/>.</disp-formula>
</p>
<p>But a nonlinear model such as above requires even more data to have a good estimate for all the parameters at each individual level. The number of time points available for most of the current TQT studies is too small. Some researchers<sup>
<xref ref-type="bibr" rid="bibr10-0092861512467018">10</xref>
</sup> have proposed other multilevel modeling to obtain a better individual correction factor. But those models require even more data points because of the complicated error structures.</p>
<p>The third approach is to use a 1-step model to study drug-induced QT effect. In this approach, RR was included as a covariate in the regression model with both fixed and random components to give each individual a unique QT-RR slope.<sup>
<xref ref-type="bibr" rid="bibr11-0092861512467018">11</xref>
</sup> The major advantage of this approach is higher model efficiency. It avoids the carrying-over estimation error encountered in 2-step individual correction. But the disadvantages include lack of flexibility to account for each individual’s unique QT-RR profile. In addition, there is no statistical tool to validate whether the heart rate effect has been sufficiently removed.</p>
<p>Since each correction method has its own advantages and disadvantages, a single correction method cannot be claimed as the best at present. The current practice is to choose one based on the prespecified methods after validating and comparing different correction methods in each study. If all the prespecified correction methods do not work well, a new correction method might also be suggested. The methods being used for comparison and validation include mixed-effects model and linear regression model for each individual. In this article, we discuss different validation methods and suggest a new approach when traditional validation models fail.</p>
</sec>
<sec id="section2-0092861512467018">
<title>Current Evaluation Procedure of Correction Methods</title>
<p>For validation and comparison of QT-RR correction methods, usually postdose data are used. Besides the visual graphic display (QTc vs RR), the following 2 approaches have been used to compare different correction methods (designated as binary variable “correction methods”). The first one is to use a mixed model set up as follows:
<disp-formula id="disp-formula5-0092861512467018">
<label>2</label>
<mml:math id="mml-disp5-0092861512467018" overflow="scroll">
<mml:mtable columnalign="right left" columnspacing="thickmathspace" displaystyle="true" rowspacing=".5em">
<mml:mtr>
<mml:mtd>
<mml:mrow>
<mml:mi mathvariant="normal">Q</mml:mi>
<mml:mi mathvariant="normal">T</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mtext> </mml:mtext>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">+</mml:mo>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mtext mathvariant="normal"> </mml:mtext>
</mml:mrow>
</mml:mrow>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">h</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">+</mml:mo>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mo stretchy="false">×</mml:mo>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mtext mathvariant="normal"> </mml:mtext>
</mml:mrow>
</mml:mrow>
<mml:mi mathvariant="normal">M</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">h</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mrow>
<mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mtext mathvariant="normal"> </mml:mtext>
</mml:mrow>
</mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">f</mml:mi>
<mml:mi mathvariant="normal">f</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mrow>
<mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mfenced close=")" open="(">
<mml:mrow>
<mml:mi mathvariant="normal">I</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">p</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">,</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mtext mathvariant="normal"> </mml:mtext>
</mml:mrow>
</mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">R</mml:mi>
</mml:mrow>
</mml:mfenced>
<mml:mrow>
<mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mo mathvariant="normal">.</mml:mo>
<mml:mrow>
<mml:mtext mathvariant="normal"> </mml:mtext>
<mml:mtext mathvariant="normal"> </mml:mtext>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alt-version="no" alternate-form-of="disp-formula5-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-eq5.tif" xlink:type="simple"/>
</disp-formula>
</p>
<p>The statistical test of the interaction term can be used to determine whether there is a significant difference between the QTc-RR slopes for any 2 correction methods. If the test is significant, then the correction method with smaller absolute values of the estimated slope is a better correction.</p>
<p>The second approach being considered is to use a linear regression of QTc on RR for each individual. Then the mean of the sum of the squares (MSSS) for all the estimated slopes of all subjects is computed. The one with the smallest MSSS is the best correction method.</p>
<p>Both approaches compare the QTc-RR slopes. A nonzero slope indicates that the QTc is still not sufficiently corrected by its RR in average. In a situation when a testing drug changes both heart rate and QTc, under the assumption that both changes are driven by the drug plasma concentration in a linear fashion,<sup>
<xref ref-type="bibr" rid="bibr12-0092861512467018">12</xref>
</sup> we may never have a zero slope of QTc versus RR mathematically, even though the RR has been perfectly corrected. For example, let conc = drug plasma concentration and suppose we have the following:
<disp-formula id="disp-formula6-0092861512467018">
<label>3</label>
<mml:math id="mml-disp6-0092861512467018" overflow="scroll">
<mml:mi mathvariant="normal">Δ</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">b</mml:mi>
<mml:mn mathvariant="italic">1</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alt-version="no" alternate-form-of="disp-formula6-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-eq6.tif" xlink:type="simple"/>
</disp-formula>
<disp-formula id="disp-formula7-0092861512467018">
<label>4</label>
<mml:math id="mml-disp7-0092861512467018" overflow="scroll">
<mml:mi mathvariant="normal">Δ</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">Q</mml:mi>
<mml:mi mathvariant="normal">T</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">×</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>b</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alt-version="no" alternate-form-of="disp-formula7-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-eq7.tif" xlink:type="simple"/>
</disp-formula>
</p>
<p>By combining <xref ref-type="disp-formula" rid="disp-formula6-0092861512467018">Equation 3</xref> and <xref ref-type="disp-formula" rid="disp-formula7-0092861512467018">Equation 4</xref>, we have <disp-formula id="disp-formula8-0092861512467018">
<label>5</label>
<mml:math id="mml-disp8-0092861512467018" overflow="scroll">
<mml:mi mathvariant="normal">Δ</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">Q</mml:mi>
<mml:mi mathvariant="normal">T</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">×</mml:mo>
<mml:mi mathvariant="normal">Δ</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alt-version="no" alternate-form-of="disp-formula8-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-eq8.tif" xlink:type="simple"/>
</disp-formula>
</p>
<p>Based on the assumptions of <xref ref-type="disp-formula" rid="disp-formula6-0092861512467018">Equations 3</xref> and <xref ref-type="disp-formula" rid="disp-formula7-0092861512467018">4</xref>, if the drug changes both heart rate and ▵QTc (α ≠ 0 and β ≠ 0) and the ratio of β to α is not too small to be ignorable, then the slope of ▵QTc versus ▵RR is not zero even if heart rate has been adequately corrected, and thus the slope cannot be used as an indicator of the goodness of QT-RR correction. In this situation, both mixed-model and MSSS approaches may not serve the purpose of evaluating the correction methods by comparing the slopes of QTc versus RR for different correction methods. The traditional validation methods may work only if both α ≠ 0 and β ≠ 0. However, since a normal procedure would be to choose the most appropriate correction method before checking whether the drug could change QTc, the traditional validation method might not work well. So after we find that the testing drug is changing the heart rate, we may not use the mixed-model or MSSS approach to evaluate and compare different correction methods. Instead, we propose the following approach for consideration.</p>
</sec>
<sec id="section3-0092861512467018">
<title>Theory and Methods</title>
<p>We assume the following mechanism for the relationship among blood plasma concentration, heart rate change, and QTc change for the test drug (<xref ref-type="fig" rid="fig1-0092861512467018">Figure 1</xref>).</p>
<fig id="fig1-0092861512467018" position="float">
<label>Figure 1.</label>
<caption>
<p>The proposed mechanism for drug concentration, QTc, and heart rate change.</p>
</caption>
<graphic alt-version="no" position="float" xlink:href="10.1177_0092861512467018-fig1.tif" xlink:type="simple"/>
</fig>
<p>In this model, we assume that the increase of drug concentration is the direct cause for both the potential heart rate change and QTc change through <italic>a</italic> and <italic>b</italic>, while another part of QTc change is caused independently by the change of heart rate at the same time. There are 3 possible situations: (I) the study drug does not change the heart rate; (II) the study drug changes only the heart rate but not QTc; and (III) the study drug changes both the heart rate and QTc. In scenario I, we can still use the current validation methods (the mixed model and MSSS). In scenario II, the model should show <italic>a</italic> ≠ 0, <italic>b</italic> = 0. In scenario III, the model should also show that <italic>a</italic> ≠ 0 and <italic>b</italic> ≠ 0. Ideally, if there is any drug effect on QTc, a corrected QT interval should only show changes caused by drug blood concentration change through <italic>b</italic> but not <italic>c</italic>, which means that <italic>c</italic> = 0 for both scenarios II and III. Using this model, we propose the following steps for validating and comparing different QTc-RR correction methods:</p>
<list list-type="order">
<list-item>
<p>Check whether the heart rate is changed by a drug through regression of RR on drug concentration. If not, then the current evaluating procedure like MSSS should work.</p>
</list-item>
<list-item>
<p>Regress QTc on RR. If RR is not significant, it means that the correction is adequate. However, the significance of RR might not indicate inadequate correction since QTc could still be related to the heart rate through the simultaneous impact of the drug on both QTc and RR. This will be clarified by introducing drug concentration in the next step.</p>
</list-item>
<list-item>
<p>Regress QTc on both RR and drug concentration. If RR was significant in step 2 but becomes nonsignificant after including concentration in the model, then QTc is an adequate correction method since the possible QTc-RR association only comes through <italic>b</italic> but not <italic>c</italic>. If RR was still significant after including concentration in the model, it indicates that this QTc might not be a good correction method.</p>
</list-item>
</list>
<p>When we compare 2 correction methods using the procedure described above, absolute values of RR slope in the regression model can be used to compare the effect of different correction methods in step 3. We will use 2 examples to demonstrate how to use the proposed procedure.</p>
</sec>
<sec id="section4-0092861512467018">
<title>Applications</title>
<sec id="section5-0092861512467018">
<title>Example 1</title>
<p>In a crossover TQT study, the testing drug was known to change the heart rate. Before data analysis, a decision needed to be made about which correction method, QTcF (Fridericia’s correction) or QTcI (the individual correction), should be used.</p>
<p>Since it was a crossover study, each individual’s ▵▵RR and ▵▵QTc can be directly computed. In step 1, the regression of ▵▵RR on drug blood concentration showed a significant association (point estimate –0.41, <italic>P</italic> &lt; .001), indicating that the drug increased the heart rate. In step 2, both ▵▵QTcF and ▵▵QTcI were regressed on ▵▵RR separately. The slopes for ▵▵RR were not statistically significantly different from zero, indicating that either the correction methods were not adequate or the study drug changed both QTc and RR simultaneously. In step 3, both ▵▵QTcF and ▵▵QTcI were regressed on ▵▵RR and drug blood concentration. The results are listed in <xref ref-type="table" rid="table1-0092861512467018">Table 1</xref>.</p>
<table-wrap id="table1-0092861512467018" position="float">
<label>Table 1.</label>
<caption>
<p>Linear Regression Model Estimates in Example 1.</p>
</caption>
<graphic alt-version="no" alternate-form-of="table1-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-table1.tif" xlink:type="simple"/>
<table>
<thead>
<tr>
<th colspan="1" rowspan="1">Outcomes of Model</th>
<th colspan="1" rowspan="1">Estimates, Concentration (<italic>P</italic> Value)</th>
<th colspan="1" rowspan="1">Estimates, ▵▵RR (<italic>P</italic> Value)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">▵▵QTcF</td>
<td colspan="1" rowspan="1">0.015 (&lt;.001)</td>
<td colspan="1" rowspan="1">–0.024 (&lt;.001)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">▵▵QTcI</td>
<td colspan="1" rowspan="1">0.019 (&lt;.001)</td>
<td colspan="1" rowspan="1">–0.014 (&lt;.001)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>For both ▵▵QTcF and ▵▵QTcI, it is shown that ▵▵RR is still significant while controlling for blood concentration, indicating that both corrections fail to eliminate the direct effect of the heart rate on QT. However, the absolute value of the slope is smaller in the model with ▵▵QTcI as outcome, indicating that QTcI might perform slightly better than QTcF.</p>
</sec>
<sec id="section6-0092861512467018">
<title>Example 2</title>
<p>In a parallel TQT study, the testing drug was known to change the heart rate, so QTcI was considered as the primary correction method.</p>
<p>Since it was a parallel study, ▵▵RR or ▵▵QTc for each individual could not be obtained directly. So the change from baseline, ▵RR, and ▵QTc for each subject were used as outcome in the model. In step 1, the regression of ▵RR on drug blood concentration showed a small but still significant association between the two (point estimate –0.004, <italic>P</italic> &lt; .001), indicating that the drug increased the heart rate.</p>
<p>In step 2, regressions of ▵QTcF and ▵QTcI on ▵RR were performed separately with both results considered to be statistically significant. Then we added drug concentration in the models as suggested in step 3. <xref ref-type="table" rid="table2-0092861512467018">Table 2</xref> shows that ▵RR became nonsignificant for both ▵QTcF and ▵QTcI. This indicates that both corrections adequately addressed the direct dependence of QT on RR. So in this example, the drug effect on the heart rate was small, and a fixed correction method such as QTcF was still adequate.</p>
<table-wrap id="table2-0092861512467018" position="float">
<label>Table 2.</label>
<caption>
<p>Linear Regression Model Estimates in Example 2.</p>
</caption>
<graphic alt-version="no" alternate-form-of="table2-0092861512467018" position="float" xlink:href="10.1177_0092861512467018-table2.tif" xlink:type="simple"/>
<table>
<thead>
<tr>
<th colspan="1" rowspan="1">Outcomes of Model</th>
<th colspan="1" rowspan="1">Estimates, Concentration (<italic>P</italic> Value)</th>
<th colspan="1" rowspan="1">Estimates, ▵RR (<italic>P</italic> Value)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">▵QTcF</td>
<td colspan="1" rowspan="1">0.0008 (&lt;.001)</td>
<td colspan="1" rowspan="1">0.0014 (.76)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">▵QtcI</td>
<td colspan="1" rowspan="1">0.0008 (&lt;.001)</td>
<td colspan="1" rowspan="1">0.0054 (.26)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="section7-0092861512467018">
<title>Discussion</title>
<p>The dependence of QT interval on the heart rate is well known, and many methods have been suggested to eliminate such an impact on QT. But so far there is no consensus on the optimal solution to be applied to all TQT studies. Therefore, the most appropriate correction method varies in each study. In this article, we pointed out that traditional approaches of comparing correction methods may fail when the testing drug could potentially change the heart rate. The 3-step solution we suggested in this article might be a potential solution for this issue.</p>
<p>The major limitation of the proposed 3-step procedure is that it relies on the assumptions of one-to-one relationship between both QTc and RR and the drug blood concentration. In reality, such an assumption may not always be true. <xref ref-type="fig" rid="fig2-0092861512467018">Figure 2</xref> plots the mean of blood concentration, ▵▵QTcF, and ▵▵RR against time from a crossover TQT study. It shows that the average blood drug concentrations are similar at 0.5 hours and 3 hours after dose. But both ▵▵RR and ▵▵QT are very different at these 2 time points. The figure indicates that at one concentration level, there can be 2 different corresponding ▵▵RR and ▵▵QT levels. This cannot be simply explained as a delayed effect since the shapes of profiles are very different too, not just a simple time shift. Besides that, even if the slope of ▵▵RR is nonsignificant after controlling for concentration, it is difficult to tell whether it is caused by lack of association or simply inadequate power.</p>
<fig id="fig2-0092861512467018" position="float">
<label>Figure 2.</label>
<caption>
<p>Example of blood concentration, ▵▵QTcF, and ▵▵RR profile.</p>
</caption>
<graphic alt-version="no" position="float" xlink:href="10.1177_0092861512467018-fig2.tif" xlink:type="simple"/>
</fig>
<p>Nevertheless, a concentration-response model has been widely used in TQT studies, and each drug can have very different profile. Before applying the 3-step validation procedure, we suggest that one should at least graphically check the one-to-one association between blood concentration, ▵RR, and ▵QTc.</p>
<p>The procedures we suggest in this article only address the issue of comparing different correction methods when the testing drug changes the heart rate; however, they do not address how to correct for heart rate in this situation. Heart rate correction is more difficult when the drug changes both QT and the heart rate. Normally when a drug changes the heart rate, the ranges of the QT interval measured at baseline and postdose might be different. The individual corrections derived from the baseline data need to be extrapolated to different heart rates for the study drug. Such extrapolation can be very unreliable if the relationship between QT and RR is not consistent at different ranges of RR.</p>
</sec>
<sec id="section8-0092861512467018">
<title>Concluding Remarks</title>
<p>It is a challenge to select appropriate QT correction methods when a drug changes the heart rate. So far there is no consensus about the standard approach. The 3-step procedure we have suggested in this article can be easily applied to compare and validate different correction methods. The idea and rationale behind this approach are simple, and it does not require intensive computation. This procedure can be used in both crossover and parallel TQT studies.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-0092861512467018">
<p>This article reflects the views of the authors and should not be construed to represent FDA's views or policies.</p>
</fn>
<fn fn-type="conflict" id="fn2-0092861512467018">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0092861512467018">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article. </p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0092861512467018">
<label>1</label>
<citation citation-type="journal" xlink:type="simple">
<collab collab-type="author" xlink:type="simple">International Conference on Harmonisation</collab>. <article-title>Guidance on E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs: availability. Notice</article-title>. <source>Fed Regist</source>. <year>2005</year>;<volume>70</volume>:<fpage>61134</fpage>–<lpage>61135</lpage>.</citation>
</ref>
<ref id="bibr2-0092861512467018">
<label>2</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Badilini</surname>
<given-names>F</given-names>
</name>
<name name-style="western">
<surname>Maison-Blanche</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Childers</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>QT interval analysis on ambulatory electrocardiogram recordings: a selective beat averaging approach</article-title>. <source>Med Biol Eng Comput</source>. <year>1999</year>;<volume>37</volume>:<fpage>71</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr3-0092861512467018">
<label>3</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Fossa</surname>
<given-names>AA</given-names>
</name>
<name name-style="western">
<surname>Wisialowski</surname>
<given-names>T</given-names>
</name>
<name name-style="western">
<surname>Magnano</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Dynamic beat-to-beat modeling of the QT-RR interval relationship: analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go–related gene inhibition</article-title>. <source>J Pharmacol Exp Ther</source>. <year>2005</year>;<volume>312</volume>:<fpage>1</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr4-0092861512467018">
<label>4</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Fossa</surname>
<given-names>AA</given-names>
</name>
<name name-style="western">
<surname>Zhou</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Assessing QT prolongation and electrocardiography restitution using a beat-to-beat method</article-title>. <source>Cardiol J</source>. <year>2010</year>;<volume>17</volume>(<issue>3</issue>):<fpage>230</fpage>ȓ<lpage>243</lpage>.</citation>
</ref>
<ref id="bibr5-0092861512467018">
<label>5</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Hosmane</surname>
<given-names>B</given-names>
</name>
<name name-style="western">
<surname>Locke</surname>
<given-names>C</given-names>
</name>
<name name-style="western">
<surname>Morris</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>QT interval: correction for heart rate</article-title>. <source>J Appl Res</source>. <year>2006</year>;<volume>6</volume>:<fpage>288</fpage>–<lpage>299</lpage>.</citation>
</ref>
<ref id="bibr6-0092861512467018">
<label>6</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Malik</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Problems of heart rate correction in the assessment of drug-induced QT interval prolongation</article-title>. <source>J Cardiovasc Electrophysiol</source>. <year>2001</year>;<volume>12</volume>:<fpage>411</fpage>–<lpage>420</lpage>.</citation>
</ref>
<ref id="bibr7-0092861512467018">
<label>7</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Malik</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Färbom</surname>
<given-names>P</given-names>
</name>
<name name-style="western">
<surname>Batchvarov</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Hnatkova</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Camm</surname>
<given-names>AJ.</given-names>
</name>
</person-group> <article-title>Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval</article-title>. <source>Heart</source>. <year>2002</year>;<volume>87</volume>:<fpage>220</fpage>–<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr8-0092861512467018">
<label>8</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Malik</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Hnatkova</surname>
<given-names>K</given-names>
</name>
<name name-style="western">
<surname>Batchvarov</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation</article-title>. <source>Pacing Clin Electrophysiol</source>. <year>2004</year>;<volume>27</volume>
<issue>(6/1)</issue>:<fpage>791</fpage>–<lpage>800</lpage>.</citation>
</ref>
<ref id="bibr9-0092861512467018">
<label>9</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Batchvarov</surname>
<given-names>V</given-names>
</name>
<name name-style="western">
<surname>Malik</surname>
<given-names>M</given-names>
</name>
<name name-style="western">
<surname>Färbom</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Individual patterns of QT/RR relationship</article-title>. <source>Cardiac Electrophysiol Rev</source>. <year>2002</year>;<volume>6</volume>:<fpage>282</fpage>–<lpage>288</lpage>.</citation>
</ref>
<ref id="bibr10-0092861512467018">
<label>10</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Ring</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>Statistical models for heart rate correction of the QT interval</article-title>. <source>Stat Med</source>. <year>2009</year>;<volume>29</volume>:<fpage>786</fpage>–<lpage>796</lpage>.</citation>
</ref>
<ref id="bibr11-0092861512467018">
<label>11</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Dmitrienko</surname>
<given-names>A</given-names>
</name>
<name name-style="western">
<surname>Smith</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Repeated-measures models in the analysis of QT interval</article-title>. <source>Pharm Stat</source>. <year>2003</year>;<volume>2</volume>(<issue>3</issue>):<fpage>175</fpage>–<lpage>190</lpage>.</citation>
</ref>
<ref id="bibr12-0092861512467018">
<label>12</label>
<citation citation-type="journal" xlink:type="simple">
<person-group person-group-type="author">
<name name-style="western">
<surname>Garnett</surname>
<given-names>CE</given-names>
</name>
<name name-style="western">
<surname>Beasley</surname>
<given-names>N</given-names>
</name>
<name name-style="western">
<surname>Atul Bhattaram</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Concentration–QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review</article-title>. <source>J Clin Pharmacol</source>. <year>2008</year>;<volume>48</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>18</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>